Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ELMD - Electromed Inc.


Close
17.15
1.070   6.239%

Share volume: 68,256
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$16.08
1.07
6.65%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
62%
Profitability 82%
Dept financing 5%
Liquidity 70%
Performance 54%
Company vs Stock growth
vs
Performance
5 Days
7.86%
1 Month
8.54%
3 Months
15.96%
6 Months
11.22%
1 Year
62.10%
2 Year
76.99%
Key data
Stock price
$17.15
P/E Ratio 
0.00
DAY RANGE
$16.06 - $17.23
EPS 
$0.00
52 WEEK RANGE
$9.53 - $18.60
52 WEEK CHANGE
$0.71
MARKET CAP 
148.157 M
YIELD 
N/A
SHARES OUTSTANDING 
8.639 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
BETA 
0.25
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$47,236
AVERAGE 30 VOLUME 
$25,325
Company detail
CEO:
Region: US
Website: electromed.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.

Recent news